| Literature DB >> 23306565 |
Guilherme Pilla Caminha1, José Tavares de Melo Junior, Claire Hopkins, Emilio Pizzichini, Marcia Margaret Menezes Pizzichini.
Abstract
UNLABELLED: Rhinosinusitis is a highly prevalent disease and a major cause of high medical costs. It has been proven to have an impact on the quality of life through generic health-related quality of life assessments. However, generic instruments may not be able to factor in the effects of interventions and treatments. SNOT-22 is a major disease-specific instrument to assess quality of life for patients with rhinosinusitis. Nevertheless, there is still no validated SNOT-22 version in our country.Entities:
Mesh:
Year: 2012 PMID: 23306565 PMCID: PMC9446342 DOI: 10.5935/1808-8694.20120030
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Figure 1Establishing the clarity of SNOT-22. This shows the clarity index from each item in the “SNOT-22”. The blue bars represent the clarity index upon the first cognitive unfolding and the red bars indicate the clarity index upon the second cognitive unfolding. The dotted line shows the cutting point of 0.80 from which each item is considered clear. We notice that items 6 and 22 are located below the clarity index upon the first stage of unfolding and that all the items in “SNOT-22” were considered clear in the second cognitive unfolding. CU: cognitive unfolding.
Final Version of the SNOT-22 Questionnaire. SNOT-22 Sinonasal Outcomes Questionnaire.
| Name:______________________Date:__/__/___ | ||||||
|---|---|---|---|---|---|---|
| Below, there is a list of symptoms and social/emotional consequences associated with your nasal problem. We would like to know more about these problems, and we appreciate your time in answering these questions to the best of your abilities. There are no correct or wrong answers, and only you can provide us with this information. Please quantify your problems and how they have presented in the last | ||||||
| A: Please, read the symptoms below, numbered from 1 to 22. Following, use the scale to the side to quantify the severity of your problem and the frequency at which it happens. To end, please circle the number corresponding to how bad you feel → | No problem | Very Mild Problem | Mild or light problem | Moderate problem | Severe problem | Very severe problem |
| 1. Need to blow your nose | 0 | 1 | 2 | 3 | 4 | 5 |
| 2. Sneezing | 0 | 1 | 2 | 3 | 4 | 5 |
| 3. Running nose | 0 | 1 | 2 | 3 | 4 | 5 |
| 4. Cough | 0 | 1 | 2 | 3 | 4 | 5 |
| 5. A feeling of secretion running down the back of your nose | 0 | 1 | 2 | 3 | 4 | 5 |
| 6. Thick secretion in the nose (thick mucous in the nose) | 0 | 1 | 2 | 3 | 4 | 5 |
| 7. Stuffed ear (clogged ear) | 0 | 1 | 2 | 3 | 4 | 5 |
| 8. Dizziness | 0 | 1 | 2 | 3 | 4 | 5 |
| 9. Ear ache | 0 | 1 | 2 | 3 | 4 | 5 |
| 10. Facial pain or pressure | 0 | 1 | 2 | 3 | 4 | 5 |
| 11. Difficulty falling asleep | 0 | 1 | 2 | 3 | 4 | 5 |
| 12. Waking up in the middle of the night | 0 | 1 | 2 | 3 | 4 | 5 |
| 13. Lack of a good night of sleep | 0 | 1 | 2 | 3 | 4 | 5 |
| 14. Wake up tired in the morning | 0 | 1 | 2 | 3 | 4 | 5 |
| 15. Tiredness/fatigue throughout the day | 0 | 1 | 2 | 3 | 4 | 5 |
| 16. Reduced productivity (lower performance) | 0 | 1 | 2 | 3 | 4 | 5 |
| 17. Reduced concentration | 0 | 1 | 2 | 3 | 4 | 5 |
| 18. Frustrated/impatient/touchy | 0 | 1 | 2 | 3 | 4 | 5 |
| 19. Sad | 0 | 1 | 2 | 3 | 4 | 5 |
| 20. Embarrassed | 0 | 1 | 2 | 3 | 4 | 5 |
| 21. Perception of olfaction (smell) or taste | 0 | 1 | 2 | 3 | 4 | 5 |
| 22. Clogged/stuffed nose | 0 | 1 | 2 | 3 | 4 | 5 |
| Total | ____ | ____ | ____ | ____ | ____ | |
| Total General_______ | ||||||
Figure 2Graphical representation as proposed by Bland and Altman – reproducibility. Scores from the first and second visit. On the Y axis, the difference between the scores from the first and second administrations of the questionnaire and, on the X axis, their mean values. The central red line indicates the difference between the scores from the first and second administrations of the questionnaire and the peripheral red lines indicate the mean ± two standard deviations (1.96 × SD). SD: Standard Deviation.